Joint U.S.-British Study Supports Military Application of Drug to Reduce Post-Trauma Bleeding

Joint U.S.-British Study Supports Military Application of Drug to Reduce Post-Trauma Bleeding

By Tiffany Holloway Hemorrhage is the leading cause of death in civilian and military trauma. Fortunately, there is hope, in the form of tranexamic acid (TXA), a synthetic derivative of the amino acid lysine. Through the United States’ Joint Theater Trauma System, which is an organized approach to providing improved trauma care across the continuum of levels of care, especially in the battlefield environment, TXA was recognized after years of observations. There was level 1 evidence in the Clinical Randomization of an Anti-fibrinolytic in Significant Haemorrhage 2 (CRASH-2) trial for the use of TXA, including a purported survival benefit in civilian trauma patients. However, the existing study performed on TXA […]